Description
Release form
Capsules
Packaging
50 units
Pharmacological action
MICRASIM is an enzyme preparation from the pancreas of animals, which includes protease, lipase and amylase, which provide the digestion of proteins, fats and carbohydrates in food.
After taking the drug, the gelatin capsule dissolves in the stomach under the action of gastric juice and pancreatin microgranules that are resistant to the acidic environment of the stomach, together with the gastric contents, enter the duodenum 12 and then into the small intestine, where digestive enzymes are released and enzymatic digestion is provided. .
Pancreatin in the form of microgranules provides faster mixing of digestive enzymes with intestinal contents and their uniform distribution in it, which provides higher digesting activity.
Enzymatic activity of pancreatin appears maximally in 30-40 minutes after oral administration.
After interaction with substrates, protease, lipase and amylase in the lower intestine lose activity and are excreted along with intestinal contents. Micrazim is not absorbed in the gastrointestinal tract and acts locally.
Indications
For replacement therapy for pancreatic enzyme deficiency associated with: hereditary diseases – cystic fibrosis (pancreatic fibrosis), chronic pancreatitis by pancreatic tumors by surgical interventions on the pancreas. Substitution therapy for pancreatic enzyme deficiency cannot replace the treatment of the underlying disease.
Symptomatic therapy in a complex treatment for the correction of digestive disorders that occur with other diseases or pathological conditions of the gastrointestinal tract: conditions after resection of the stomach, gall bladder, part of the intestine diseases and conditions accompanied by impaired bile secretion (liver disease, cholecystitis, gall stones bladder disease, chronic diseases of the biliary tract, compression of the biliary tract by neoplasms, cystic growths, etc.)
disease niyah of the small intestine and duodenum, large intestine, accompanied by impaired promotion of intestinal contents.
To improve the digestion of food in adults and children with normal gastrointestinal function in case of:
inaccuracies in the diet (eating greasy and rough foods, overeating, irregular eating) with impaired chewing function, a sedentary lifestyle, and prolonged immobilization.
For use in the comprehensive preparation for x-ray examination and ultrasound of the abdominal organs.
Contraindications
Acute pancreatitis, exacerbation of chronic pancreatitis, individual intolerance to pancreatin or certain components of the drug.
Use during pregnancy and lactation
There are no data on potential risks of using pancreatin in pregnant women and lactation, therefore, the drug should be prescribed to pregnant and lactating mothers only if the beneficial effect exceeds the possible risks.
Special instructions
Children and adults who have been receiving significant doses of pancreatin therapy for a long time should be monitored regularly by a specialist.
The main reasons for the ineffectiveness of enzyme therapy are: inactivation of enzymes in the duodenum as a result of acidification of its contents, concomitant diseases of the small intestine (helminthic invasions, dysbiosis) duodenostasis patients do not use the recommended treatment regimen using enzymes that have lost their activity.
Composition of
Active ingredient:
10000 PIECES of Pancreatin in the form of enteric-soluble pellets (microgranules).
Excipients:
pellet shell (microgranules):
eudragit E-100 (methyl methacrylate, dimethylaminoethyl methacrylate and butyl methacrylate copolymer),
triethyl citrate, srdlklp
methyl parahydroxybenzoate (methyl paraben, nipagin),
propyl parahydroxybenzoate (propyl paraben)
dyes:
dye crimson (ponceau 4R),
dye quinoline yellow,
dye patented blue,
titanium dioxide.
Side effects
Allergic reactions.
Drug Interactions
Reduces iron absorption.
Overdose
Symptoms: Increased uric acid content in the urine (hyperuricuria) and blood (hyperuricemia). Children have constipation.
Treatment: withdrawal of the drug, symptomatic therapy.
Storage Conditions
In a dry, dark place and out of the reach of children, at a temperature not exceeding 25 ° C.
Shelf life
2 years
Deystvuyushtee substance
Pancreatin
Terms and conditions otpuska IZ
pharmacies without a prescription
Dosage
capsule form
Possible product names
MICRASIM 10000ED N50 CAPS
MICRASIM 10000ED CAPS. N50
Micrasim 10000ED Caps. X50 (blisters) (R)
MICRASIM 10000ED No. 50 CAPS.
Micrazim caps 10000ED N50 (pack contact N10x5) ind pack
